Search for Clinical Trial Results
Anaplastic Plasmacytoma - 139 Studies Found
| Status | Study |
| Recruiting |
Study Name: Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Condition: Plasmacytoma Date: 2015-07-28 Interventions:
|
| Recruiting |
Study Name: Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Condition: Solitary Osseous Plasmacytoma Date: 2015-08-04 Interventions:
|
| Terminated |
Study Name: S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Condition:
Date: 2005-05-03 Interventions:
|
| Terminated |
Study Name: CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Condition: Extramedullary Plasmacytoma Date: 2015-01-08 Interventions:
|
| Completed |
Study Name: Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma Condition:
Date: 2009-10-01 Interventions: Biological: autologous idiotype-protein pulsed dendritic cells Vaccination with autologous idiotype-prot |
| Completed |
Study Name: Phase I/II Study of hLL1 in Multiple Myeloma Condition:
|
| Recruiting |
Study Name: Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Condition:
|
| Not yet recruiting |
Study Name: MDM2 Inhibitor AMG-232, Carfilzomib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma Condition:
|
| Completed |
Study Name: Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation Condition:
|